Disclosures for "Tirzepatide versus Semaglutide in the Risk of Cerebral Infarction in Patients with Diagnosis of Type 2 Diabetes Mellitus: A Propensity Score Matching from a Global Federated Health Network Analysis"
-
Mrs. Maximiano has nothing to disclose.
-
Mr. Batista has nothing to disclose.
-
Mr. Cian da Cruz has nothing to disclose.
-
Dr. Rodrigues Cal has nothing to disclose.
-
Dr. Haddad Santos has nothing to disclose.